|
Volumn 39, Issue 8, 2009, Pages 1999-2003
|
25 Years of HIV research!... and what about a vaccine?
|
Author keywords
AIDS; Diversity; T cells; Vaccine
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INTEGRASE INHIBITOR;
PLACEBO;
PLASMID DNA;
PROTEINASE INHIBITOR;
RECOMBINANT GLYCOPROTEIN GP 120;
RECOMBINANT INTERLEUKIN 2;
ANTIVIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CELL THERAPY;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNITY;
IMMUNIZATION;
IMMUNOGENICITY;
IMMUNOTHERAPY;
NONHUMAN;
PANDEMIC;
PATHOGENESIS;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REVIEW;
T LYMPHOCYTE;
ANIMAL;
ANTIBODY PRODUCTION;
ARTICLE;
DISEASE MODEL;
DRUG EFFECT;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IMMUNOLOGY;
MACACA;
MEDICAL RESEARCH;
METHODOLOGY;
MONKEY DISEASE;
SIMIAN IMMUNODEFICIENCY VIRUS;
TREATMENT OUTCOME;
VIROLOGY;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
ANIMALS;
ANTIBODY FORMATION;
ANTIVIRAL AGENTS;
BIOMEDICAL RESEARCH;
DISEASE MODELS, ANIMAL;
HIV-1;
HUMANS;
MACACA;
SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;
SIMIAN IMMUNODEFICIENCY VIRUS;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
EID: 70249103853
PISSN: 00142980
EISSN: 15214141
Source Type: Journal
DOI: 10.1002/eji.200939551 Document Type: Review |
Times cited : (8)
|
References (52)
|